Literature DB >> 11168308

Factors in older cadaveric organ donors impacting on renal allograft outcome.

D J Verran1, C deLeon, A K Chui, J R Chapman.   

Abstract

Transplantation of renal allografts (RA) from older donors has become more common, despite conflicting data on outcome between reports from large series versus individual centres. Factors other than donor age per se may contribute to RA outcome. The outcome of RA procured from 114 older donors over 55 yr of age in NSW, between 1990 and 1997, was analysed. Corresponding donor factors, including demographics, medical history, inotrope use, major hypotension and findings at procurement, were also analysed. Of the potential RA, 8% were discarded and the remainder transplanted. Factors significantly associated with renal discard were pre-transplantation donation biopsy abnormality (p < 0.001) and a history of cardiovascular (CV) disease in the donor (p < 0.02). Donor aortorenal atherosclerosis (AS; p < 0.09) and a donor age of 65 yr or older (p < 0.08) were common in the discard group. The never function rate was 7.6% and was associated with a history of a discarded partner kidney (p < 0.05). The delayed graft function rate was 33% and was associated with a history of donor CV disease. At a median follow up of 5 yr, the death censored allograft failure rate was 24%. Allograft failure was associated with a history of donor hypertension (p < 0.05). Donor AS (p < 0.7) tended to have been more common in the allograft failure group. A number of cadaveric organ donor factors documented at procurement may be associated with inferior outcome of RA. These include biopsy abnormality, history of donor CV disease and history of donor hypertension. A donor age of 65 yr or older or significant visible aortorenal AS may also be factors. This retrospective review of kidneys procured from 114 older cadaveric organ donors identifies factors apart from donor age, which may have a negative impact on both allograft utilisation and outcome. Theses factors include renal biopsy abnormality, history of donor CV disease, discard of a partner kidney and donor hypertension. Visible AS in the donor aorta documented at renal procurement may also be a factor.

Entities:  

Mesh:

Year:  2001        PMID: 11168308     DOI: 10.1034/j.1399-0012.2001.150101.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  5 in total

Review 1.  Strategies for an Expanded Use of Kidneys From Elderly Donors.

Authors:  María José Pérez-Sáez; Núria Montero; Dolores Redondo-Pachón; Marta Crespo; Julio Pascual
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

2.  [Kidney donors and kidney transplantation in the elderly].

Authors:  M Giessing; S Conrad; B Schönberger; H Huland; K Budde; H-H Neumayer; S A Loening
Journal:  Urologe A       Date:  2004-08       Impact factor: 0.639

Review 3.  Drug therapy in transplant recipients: special considerations in the elderly with comorbid conditions.

Authors:  José F Bernardo; Jerry McCauley
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

4.  Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine.

Authors:  Mahmoud Kamel; Manish Kadian; Titte Srinivas; David Taber; Maria Aurora Posadas Salas
Journal:  World J Transplant       Date:  2016-12-24

Review 5.  Cost-effectiveness of Deceased-donor Renal Transplant Versus Dialysis to Treat End-stage Renal Disease: A Systematic Review.

Authors:  Rui Fu; Nigar Sekercioglu; Whitney Berta; Peter C Coyte
Journal:  Transplant Direct       Date:  2020-01-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.